Atlas Trials

Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer

Clinical trial NCT00078494 · COMPLETED

Trial details

NCT number
NCT00078494
Sponsor
National Institutes of Health Clinical Center (CC)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Nasopharyngeal Neoplasms
Start date
2004-02-01
Enrollment
99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.